Pages that link to "Q42910760"

The following pages link to Biochemical and functional characterization of germ line KRAS mutations (Q42910760):

Displaying 47 items.

• Monoallelic and biallelic mutations in MAB21L2 cause a spectrum of major eye malformations (Q24298949) (← links)
• The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation (Q24655603) (← links)
• The RASopathies (Q27022142) (← links)
• A Conserved Phenylalanine as a Relay between the  5 Helix and the GDP Binding Region of Heterotrimeric Gi Protein   Subunit (Q27684726) (← links)
• RAS diseases in children (Q28252058) (← links)
• A Gain-of-Function Germline Mutation in Drosophila ras1 Affects Apoptosis and Cell Fate during Development (Q28476541) (← links)
• Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia (Q30432448) (← links)
• Computation of conformational coupling in allosteric proteins (Q30872872) (← links)
• Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum (Q33637874) (← links)
• Noonan syndrome: clinical aspects and molecular pathogenesis (Q33806161) (← links)
• Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia (Q34130332) (← links)
• Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species (Q34259118) (← links)
• Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations (Q34299378) (← links)
• Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms (Q34440570) (← links)
• Noonan syndrome and clinically related disorders (Q34678373) (← links)
• Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery (Q34687101) (← links)
• Specific activation of K-RasG12D allele in the bladder urothelium results in lung alveolar and vascular defects (Q35156169) (← links)
• Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site (Q35669207) (← links)
• KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant (Q35828637) (← links)
• KRAS insertion mutations are oncogenic and exhibit distinct functional properties (Q36564695) (← links)
• Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo (Q36928333) (← links)
• High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients (Q37109358) (← links)
• Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway (Q37343475) (← links)
• Differences in the regulation of K-Ras and H-Ras isoforms by monoubiquitination (Q37415584) (← links)
• Lymphatic vessel abnormalities arising from disorders of Ras signal transduction (Q38158991) (← links)
• Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention (Q38261370) (← links)
• Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes (Q39260997) (← links)
• Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors. (Q39579262) (← links)
• Mechanistic modeling to investigate signaling by oncogenic Ras mutants (Q39727752) (← links)
• Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders (Q42049635) (← links)
• NRAS Mutations in Noonan Syndrome. (Q42215601) (← links)
• Pathogenetics of the RASopathies. (Q45957290) (← links)
• A novel approach using long-read sequencing and ddPCR to investigate gonadal mosaicism and estimate recurrence risk in two families with developmental disorders (Q47139897) (← links)
• KRAS Alleles: The Devil Is in the Detail (Q49668169) (← links)
• RAS GTPase mutants don't hydrolyze GTP (Q50288910) (← links)
• Behavioral phenotype in Costello syndrome with atypical mutation: a case report (Q50303363) (← links)
• Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature. (Q52992343) (← links)
• K-Ras(V14I) -induced Noonan syndrome predisposes to tumour development in mice. (Q53101926) (← links)
• Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. (Q54505431) (← links)
• Behavioral Profile in RASopathies (Q58881431) (← links)
• Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer's Precision Medicine and Pharmacology (Q64102563) (← links)
• Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing (Q86896357) (← links)
• The microRNA-200 family acts as an oncogene in colorectal cancer by inhibiting the tumor suppressor RASSF2 (Q90354931) (← links)
• GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRASP34R (Q90432215) (← links)
• A de novo variant in RAC3 causes severe global developmental delay and a middle interhemispheric variant of holoprosencephaly (Q92669008) (← links)
• Neurodevelopmental Aspects of RASopathies (Q93096512) (← links)
• RAS GAP mutants aren't stimulated by GAPs (Q100152456) (← links)